{
    "clinical_study": {
        "@rank": "9978", 
        "acronym": "PLACE II", 
        "arm_group": {
            "arm_group_label": "Treatment", 
            "arm_group_type": "Experimental", 
            "description": "LAA exclusion with the LARIAT Suture Delivery Device"
        }, 
        "brief_summary": {
            "textblock": "Evaluate the safety and effectiveness of the LARIAT Suture Delivery device in excluding the\n      left atrial appendage in 100 patients."
        }, 
        "brief_title": "Left Atrial Appendage Exclusion Study", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Atrial Appendage", 
        "detailed_description": {
            "textblock": "The objective of this study is to evaluate the safety and effectiveness of the SentreHEART\n      suture delivery system for the exclusion of the left atrial appendage in up to 100 treated\n      patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subject is greater than or equal to 18 years of age\n\n          2. Subject has atrial fibrillation (paroxysmal or persistent)\n\n          3. Subject is poor candidate for Warfarin (contraindicated, labile INR, non-compliant)\n\n          4. Subject is willing and able to provide written informed consent\n\n          5. Subject has a life expectancy of at least 1 year\n\n          6. Subject is willing and able to return for scheduled follow up visits\n\n        Exclusion Criteria:\n\n          1. Previous cardiac surgery\n\n          2. Thrombus in the left atrial appendage or left atrium\n\n          3. NYHA Class IV heart failure symptoms\n\n          4. Need for emergent cardiac surgery (i.e. cardiogenic shock)\n\n          5. LAA is not appropriate for exclusion based upon intraoperative evaluations\n\n          6. Current diagnosis of active systemic infection\n\n          7. Renal failure requiring dialysis or hepatic failure\n\n          8. A known drug and/or alcohol addiction\n\n          9. Mental impairment or other conditions, which may not allow subject to understand the\n             nature, significance and scope of the study\n\n         10. Pregnancy or desire to get pregnant within 12 months of the study treatment\n\n         11. Preoperative need for an intra-aortic balloon pump or intravenous inotropes\n\n         12. Patients who have been treated with thoracic radiation\n\n         13. Patients in current chemotherapy\n\n         14. Patients on long-term treatment with steroids not including intermittent use of\n             inhaled steroids for respiratory diseases.\n\n         15. Patients with known connective tissue disorders, i.e. Lupus\n\n         16. Previous history of pericarditis\n\n         17. Presence of a PFO/ASD or valve implant"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01983605", 
            "org_study_id": "RS-001 V3.0_120709"
        }, 
        "intervention": {
            "arm_group_label": "Treatment", 
            "description": "LAA exclusion procedure", 
            "intervention_name": "LARIAT Suture Delivery Device", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 13, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Krakow", 
                    "country": "Poland"
                }, 
                "name": "Jagiellonian University (John Paul II) Hospital"
            }
        }, 
        "location_countries": {
            "country": "Poland"
        }, 
        "number_of_arms": "1", 
        "official_title": "Left Atrial Appendage Exclusion Study II", 
        "overall_official": {
            "affiliation": "Jagiellonian University (John Paul II) Hospital", 
            "last_name": "Jerzy Sadowski, M.D., Ph.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Poland: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Rate of device related serious adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Percent of patients with complete exclusion of the LAA measured with TEE", 
                "safety_issue": "No", 
                "time_frame": "90 days"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01983605"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "23062528", 
            "citation": "Bartus K, Han FT, Bednarek J, Myc J, Kapelak B, Sadowski J, Lelakowski J, Bartus S, Yakubov SJ, Lee RJ. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol. 2013 Jul 9;62(2):108-18. doi: 10.1016/j.jacc.2012.06.046. Epub 2012 Oct 10."
        }, 
        "source": "SentreHEART, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "SentreHEART, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2009", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}